PE20010984A1 - Derivados de nitrilo como inhibidores de catepsina k - Google Patents
Derivados de nitrilo como inhibidores de catepsina kInfo
- Publication number
- PE20010984A1 PE20010984A1 PE2000001382A PE0013822000A PE20010984A1 PE 20010984 A1 PE20010984 A1 PE 20010984A1 PE 2000001382 A PE2000001382 A PE 2000001382A PE 0013822000 A PE0013822000 A PE 0013822000A PE 20010984 A1 PE20010984 A1 PE 20010984A1
- Authority
- PE
- Peru
- Prior art keywords
- aryl
- heteroaryl
- cycloalkyl
- alkyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE A DERIVADOS DE NITRILO DE FORMULA I DONDE Y ES O, S, CH-R2; R1 Y R3 SON H, METILO; O R2 Y R3 SON CH2 PARA FORMAR CICLOPROPILO; R4 Y R5 SON H, ALQUILO; R6 ES CICLOALQUILO, ARILO, ARIL-ALQUILO, HETEROARILO, HETEROARILALQUILO; R7 ES CORa, SO2Rb, CSNHRc; Ra ES ALQUILO, CICLOALQUILO, ARILO, HETEROARILO, ENTRE OTROS; Rb ES ALQUILO, CICLOALQUILO, ARILO, HETEROARILO; Rc ES ALQUILO, CICLOALQUILO, ARILO, HETEROARILO. SON COMPUESTOS PREFERIDOS ACIDO (S)-2-[(R)-(BENZO[1,3]DIOXOL-5-IL-CIANO-METIL)-CARBAMOIL]-PIRROLIDIN-1-CARBOXILICO BENCIL ESTER; ACIDO (S)-1-[2-(3-BROMO-FENIL)-ETANOIL]-PIRROLIDIN-2-CARBOXILICO (1-BENZO[1,3]DIOXOL-5-IL-1-CIANO-METIL)-AMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN INHBIDOR DE PROTEASAS CISTEINICAS Y PUEDE SER UTIL PARA EL TRATAMIENTO DE OSTEOPOROSIS, OSTEOARTRITIS, ARTRITIS REUMATOIDE, METASTASIS TUMORAL, GLOMERULONEFRITIS, ATEROSCLEROSIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99125857 | 1999-12-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010984A1 true PE20010984A1 (es) | 2001-09-29 |
Family
ID=8239727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000001382A PE20010984A1 (es) | 1999-12-24 | 2000-12-21 | Derivados de nitrilo como inhibidores de catepsina k |
Country Status (18)
Country | Link |
---|---|
US (1) | US6531612B2 (es) |
EP (1) | EP1244621B1 (es) |
JP (1) | JP3808772B2 (es) |
KR (1) | KR100468254B1 (es) |
CN (1) | CN1240681C (es) |
AR (1) | AR027074A1 (es) |
AT (1) | ATE339404T1 (es) |
AU (1) | AU783145B2 (es) |
BR (1) | BR0016699A (es) |
CA (1) | CA2395179A1 (es) |
CO (1) | CO5251410A1 (es) |
DE (1) | DE60030768T2 (es) |
ES (1) | ES2270898T3 (es) |
MX (1) | MXPA02006163A (es) |
PE (1) | PE20010984A1 (es) |
UY (1) | UY26504A1 (es) |
WO (1) | WO2001047886A1 (es) |
ZA (1) | ZA200204397B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9723407D0 (en) * | 1997-11-05 | 1998-01-07 | Ciba Geigy Ag | Organic compounds |
GB0003111D0 (en) * | 2000-02-10 | 2000-03-29 | Novartis Ag | Organic compounds |
CN1315806C (zh) * | 2001-12-04 | 2007-05-16 | 霍夫曼·拉罗奇有限公司 | 取代的2-氨基-环烷烃甲酰胺和它们作为半胱氨酸蛋白酶抑制剂的用途 |
US7405234B2 (en) * | 2002-05-17 | 2008-07-29 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
EP1567487A4 (en) * | 2002-11-15 | 2005-11-16 | Bristol Myers Squibb Co | OPEN-CHAINED, PROLYL-FROSTED MODULATORS OF ANDROGEN RECEPTOR FUNCTION |
US7256208B2 (en) * | 2003-11-13 | 2007-08-14 | Bristol-Myers Squibb Company | Monocyclic N-Aryl hydantoin modulators of androgen receptor function |
US7820702B2 (en) * | 2004-02-04 | 2010-10-26 | Bristol-Myers Squibb Company | Sulfonylpyrrolidine modulators of androgen receptor function and method |
US20050182105A1 (en) * | 2004-02-04 | 2005-08-18 | Nirschl Alexandra A. | Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function |
US7696241B2 (en) * | 2004-03-04 | 2010-04-13 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
US7625923B2 (en) | 2004-03-04 | 2009-12-01 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
US7388027B2 (en) * | 2004-03-04 | 2008-06-17 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
US20090005323A1 (en) * | 2005-01-19 | 2009-01-01 | Michael David Percival | Cathepsin K Inhibitors and Obesity |
EP1841730A4 (en) * | 2005-01-19 | 2010-10-27 | Merck Frosst Canada Ltd | CATHEPSIN K INHIBITORS AND ATHEROSCLEROSIS |
AU2006274959A1 (en) * | 2005-07-27 | 2007-02-08 | F. Hoffmann-La Roche Ag | Cathepsin K inhibitors |
US20080227823A1 (en) * | 2007-03-12 | 2008-09-18 | Hassan Pajouhesh | Amide derivatives as calcium channel blockers |
CN101970007A (zh) | 2007-06-08 | 2011-02-09 | 日本化学医药株式会社 | 脑动脉瘤的治疗或预防药 |
US8309596B2 (en) * | 2007-06-28 | 2012-11-13 | Novartis Ag | Kallikrein 7 modulators |
KR100877394B1 (ko) * | 2007-07-11 | 2009-01-07 | 한국화학연구원 | 카보니트릴 화합물을 포함하는 골다공증 및 치은 질환의치료 및 예방을 위한 약제학적 조성물 |
US20100331545A1 (en) * | 2007-10-24 | 2010-12-30 | Nippon Chemiphar Co., Ltd. | Regulator for signaling toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
EA201000958A1 (ru) | 2007-12-12 | 2010-12-30 | Астразенека Аб | Пептидилнитрилы и их применение в качестве ингибиторов дипептидилпептидазы i |
JP5587790B2 (ja) | 2008-01-09 | 2014-09-10 | アミュラ セラピューティクス リミティド | 化合物 |
SI2421826T1 (sl) * | 2009-04-20 | 2014-02-28 | F. Hoffmann-La Roche Ag | Derivati prolina kot inhibitorji katepsina |
AU2010244218B2 (en) | 2009-05-07 | 2012-07-19 | Astrazeneca Ab | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750 |
US7893099B2 (en) * | 2009-06-11 | 2011-02-22 | Hoffman-La Roche Inc. | Cyclopentane derivatives |
GB0913345D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | New combination 802 |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
US8524710B2 (en) * | 2010-11-05 | 2013-09-03 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
GB201021979D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | New compound |
GB201021992D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | Compound |
US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
WO2014140091A1 (en) * | 2013-03-14 | 2014-09-18 | Boehringer Ingelheim International Gmbh | Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c |
EP4368610A1 (en) * | 2021-08-02 | 2024-05-15 | The Global Health Drug Discovery Institute | 3cl protease small-molecule inhibitor for treating or preventing coronavirus infection, and use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3606480A1 (de) * | 1986-02-28 | 1987-09-03 | Behringwerke Ag | Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung |
US4927909A (en) | 1987-09-18 | 1990-05-22 | Hoechst Celanese Corp. | Fabrication of high performance polybenzimidazole films |
AU3359697A (en) * | 1996-07-08 | 1998-02-02 | Yamanouchi Pharmaceutical Co., Ltd. | Bone resorption inhibitors |
US6015790A (en) * | 1997-10-06 | 2000-01-18 | Basf Aktiengesellschaft | Methods and compositions for treating rheumatoid arthritis |
TR200001189T2 (tr) | 1997-11-05 | 2000-09-21 | Novartis Ag. | Dipeptid nitriller. |
DK1178958T3 (da) * | 1999-03-15 | 2004-06-21 | Axys Pharm Inc | N-cyanomethylamider som proteaseinhibitorer |
-
2000
- 2000-12-13 WO PCT/EP2000/012646 patent/WO2001047886A1/en active IP Right Grant
- 2000-12-13 BR BR0016699-5A patent/BR0016699A/pt not_active IP Right Cessation
- 2000-12-13 JP JP2001549358A patent/JP3808772B2/ja not_active Expired - Fee Related
- 2000-12-13 DE DE60030768T patent/DE60030768T2/de not_active Expired - Fee Related
- 2000-12-13 KR KR10-2002-7008003A patent/KR100468254B1/ko not_active IP Right Cessation
- 2000-12-13 MX MXPA02006163A patent/MXPA02006163A/es active IP Right Grant
- 2000-12-13 CN CNB008175810A patent/CN1240681C/zh not_active Expired - Fee Related
- 2000-12-13 AT AT00990733T patent/ATE339404T1/de not_active IP Right Cessation
- 2000-12-13 EP EP00990733A patent/EP1244621B1/en not_active Expired - Lifetime
- 2000-12-13 ES ES00990733T patent/ES2270898T3/es not_active Expired - Lifetime
- 2000-12-13 AU AU30106/01A patent/AU783145B2/en not_active Ceased
- 2000-12-13 CA CA002395179A patent/CA2395179A1/en not_active Abandoned
- 2000-12-21 CO CO00097102A patent/CO5251410A1/es not_active Application Discontinuation
- 2000-12-21 PE PE2000001382A patent/PE20010984A1/es not_active Application Discontinuation
- 2000-12-21 AR ARP000106868A patent/AR027074A1/es unknown
- 2000-12-21 US US09/745,675 patent/US6531612B2/en not_active Expired - Fee Related
- 2000-12-22 UY UY26504A patent/UY26504A1/es not_active Application Discontinuation
-
2002
- 2002-05-31 ZA ZA200204397A patent/ZA200204397B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20020067559A (ko) | 2002-08-22 |
BR0016699A (pt) | 2002-11-05 |
UY26504A1 (es) | 2001-06-29 |
AU783145B2 (en) | 2005-09-29 |
US20010008901A1 (en) | 2001-07-19 |
EP1244621A1 (en) | 2002-10-02 |
AU3010601A (en) | 2001-07-09 |
AR027074A1 (es) | 2003-03-12 |
US6531612B2 (en) | 2003-03-11 |
WO2001047886A1 (en) | 2001-07-05 |
CN1413193A (zh) | 2003-04-23 |
CO5251410A1 (es) | 2003-02-28 |
ZA200204397B (en) | 2003-11-26 |
CA2395179A1 (en) | 2001-07-05 |
MXPA02006163A (es) | 2002-12-05 |
ES2270898T3 (es) | 2007-04-16 |
DE60030768T2 (de) | 2007-11-08 |
KR100468254B1 (ko) | 2005-01-27 |
EP1244621B1 (en) | 2006-09-13 |
DE60030768D1 (en) | 2006-10-26 |
ATE339404T1 (de) | 2006-10-15 |
CN1240681C (zh) | 2006-02-08 |
JP2003519125A (ja) | 2003-06-17 |
JP3808772B2 (ja) | 2006-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20010984A1 (es) | Derivados de nitrilo como inhibidores de catepsina k | |
RU2469039C2 (ru) | Способ получения клопидогреля и его производных | |
PE20021014A1 (es) | Derivados de glutaramida sustituida con n-fenpropilciclopentilo como inhibidores de nep para fsad | |
PE20030418A1 (es) | Pirrolo pirimidinas como inhibidores de cisteina proteasas | |
PE20050232A1 (es) | Metodo y composiciones para tratar la artritis reumatoide | |
RS52771B (en) | CARBAMOIL-CYCLOHEXANE DERIVATIVES (TIO) AS AN D3 / D2 RECEPTOR ANTAGONISTS | |
EA200600358A1 (ru) | Фенил- или пиридиламидные соединения в качестве антагонистов простагландина е2 | |
HK1118549A1 (en) | Methods and compounds for preparing cc-1065 analogs | |
PE20001340A1 (es) | 4-amino-azepan-3-ona como inhibidores de proteasas | |
PE20021005A1 (es) | Quinazolinas como inhibidores de mmp-13 | |
DE602004016174D1 (de) | Substituierte indazolyl(indolyl)maleimid-derivate als kinase inhibitoren | |
PE20011233A1 (es) | Compuestos alquil aminoazepan-3-ona como inhibidores de proteasas | |
PE20030723A1 (es) | Derivados de heteroaril nitrilos como inhibidores de la catepsina k | |
EA200201071A1 (ru) | Циклопентилзамещенные производные глутарамида в качестве ингибиторов нейтральной эндопептидазы | |
AR035111A1 (es) | Procedimiento para preparar un compuesto de pirimidinona | |
PE68599A1 (es) | Inhibidores de proteasas | |
UY27485A1 (es) | Compuestos pirimidina de anillo fusionado alquinilado | |
MXPA04000357A (es) | COMPUESTO QUE CONTIENE AMIDA Y TIENE UNA MEJOR SOLUBILIDAD, Y MeTODO PARA MEJORAR LA SOLUBILIDAD DE UN COMPUESTO QUE CONTIENE AMIDA. | |
DK1129087T3 (da) | Fremgangsmåde til racemisering | |
PE20030858A1 (es) | Acidos 3-(imidazolil)-2-aminopropanoicos | |
Katritzky et al. | N-Acylation of sulfonamides using N-acylbenzotriazoles | |
TW200609214A (en) | Process for the synthesis c-2, c-3 substituted n-alkylated indoles useful as cpla2 inhibitors | |
ES2230139T3 (es) | Procedimiento de preparacion de compuestos de benzoperhidroisoindol. | |
PE20001486A1 (es) | Compuestos etereos anular de 7 a 14 miembros como inhibidores de proteasas | |
AR037387A1 (es) | Proceso para la preparacion de amidas de acido alfa-hidroxicarboxilico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |